Market Research Life Sciences Market Research Pharmaceuticals Market Research Therapeutic Area Market Research CNS/Neurology Market Research

Bioanalytical Testing Services Market (Product Type: Cell-based Assays, Virology Testing, Serology, Immunogenicity & Neutralizing Antibodies, Toxicology Services, Biomarker Testing, and Pharmacokinetic Testing) - Global Industry Analysis, Size, Share, Gro

Best Price Guarantee Length Publisher Published Date SKU
from $5,795 211 Pages Transparency Market Research Pvt. Ltd. July, 2022 TNPR17372878
Best Price Guarantee
Price from $5,795
Length 211 Pages
Publisher Transparency Market Research Pvt. Ltd.
Published Date July, 2022
SKU TNPR17372878

Bioanalytical Testing Services Market (Product Type: Cell-based Assays, Virology Testing, Serology, Immunogenicity & Neutralizing Antibodies, Toxicology Services, Biomarker Testing, and Pharmacokinetic Testing) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Bioanalytical Testing Services Market – Scope of Report
TMR’s report on the global bioanalytical testing services market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global bioanalytical testing services market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global bioanalytical testing services market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the bioanalytical testing services market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global bioanalytical testing services market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global bioanalytical testing services market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global bioanalytical testing services market.

The report delves into the competitive landscape of the global bioanalytical testing services market. Key players operating in the global bioanalytical testing services market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global bioanalytical testing services market profiled in this report.

RESEARCH METHODOLOGY

The research methodology will be a combination of exhaustive primary and secondary research to analyze the market bioanalytical testing services.

Secondary Research

Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.

Secondary research sources that we typically refer, but are not limited to:

Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market

Specific Secondary Sources:

Industry Sources:
WorldWideScience.org
Elsevier, Inc.
National Institutes of Health (NIH)
PubMed
NCBI
Department of Health Care Service
Trade Data Sources
Trade Map
UN Comtrade
Trade Atlas
Company Information
OneSource Business Browser
Hoover’s
Factiva
Bloomberg
Mergers & Acquisitions
Thomson Mergers & Acquisitions
MergerStat
Profound

Primary Research

During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.

We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:

Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies

Participants who typically take part in such a process include, but are not limited to:

Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals

List of primary participants, but not limited to:

Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.

Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.

Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:

Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities

Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.


1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Bioanalytical Testing Services Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Bioanalytical Testing Services Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Technological Advancements
5.2. Pipeline Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemics Impact on Industry (value chain and short / mid / long term impact)
6. Global Bioanalytical Testing Services Market Analysis and Forecast, by Testing Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Testing Type, 2017–2031
6.3.1. Cell-based Assays
6.3.2. Virology Testing
6.3.3. Serology, Immunogenicity, and Neutralizing Antibodies
6.3.4. Toxicology Services
6.3.5. Biomarker Testing
6.3.6. Pharmacokinetic Testing
6.3.7. Other services
6.4. Market Attractiveness Analysis, by Testing Type
7. Global Bioanalytical Testing Services Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2017–2031
7.3.1. Oncology
7.3.2. Metabolic Disorders
7.3.3. Neurology
7.3.4. Hematology
7.3.5. Orthopedics
7.3.6. Immunology
7.3.7. Other
7.4. Market Attractiveness Analysis, by Application
8. Global Bioanalytical Testing Services Market Analysis and Forecast, by Technology
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Technology, 2017–2031
8.3.1. Mass Spectrometry
8.3.2. Chromatography
8.3.3. Others
8.4. Market Attractiveness Analysis, by Technology
9. Global Bioanalytical Testing Services Market Analysis and Forecast, by End-user
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast, by End-user, 2017–2031
9.3.1. Healthcare Institutes
9.3.2. Biotech & Pharmaceuticals Company
9.3.3. CDMO & CMO
9.3.4. Clinical Research Organizations
9.4. Market Attractiveness Analysis, by End-user
10. Global Bioanalytical Testing Services Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness Analysis, by Region
11. North America Bioanalytical Testing Services Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Testing Type, 2017–2031
11.2.1. Cell-based Assays
11.2.2. Virology Testing
11.2.3. Serology, Immunogenicity, and Neutralizing Antibodies
11.2.4. Toxicology Services
11.2.5. Biomarker Testing
11.2.6. Pharmacokinetic Testing
11.2.7. Other services
11.3. Market Value Forecast, by Application, 2017–2031
11.3.1. Oncology
11.3.2. Metabolic Disorders
11.3.3. Neurology
11.3.4. Hematology
11.3.5. Orthopedics
11.3.6. Immunology
11.3.7. Other
11.4. Market Value Forecast, by Technology, 2017–2031
11.4.1. Mass Spectrometry
11.4.2. Chromatography
11.4.3. Others
11.5. Market Value Forecast, by End-user, 2017–2031
11.5.1. Healthcare Institutes
11.5.2. Biotech & Pharmaceuticals Company
11.5.3. CDMO & CMO
11.5.4. Clinical Research Organizations
11.6. Market Value Forecast, by Country, 2017–2031
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Testing Type
11.7.2. By Application
11.7.3. By Technology
11.7.4. By End-user
11.7.5. By Country
12. Europe Bioanalytical Testing Services Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Testing Type, 2017–2031
12.2.1. Cell-based Assays
12.2.2. Virology Testing
12.2.3. Serology, Immunogenicity, and Neutralizing Antibodies
12.2.4. Toxicology Services
12.2.5. Biomarker Testing
12.2.6. Pharmacokinetic Testing
12.2.7. Other Services
12.3. Market Value Forecast, by Application, 2017–2031
12.3.1. Oncology
12.3.2. Metabolic Disorders
12.3.3. Neurology
12.3.4. Hematology
12.3.5. Orthopedics
12.3.6. Immunology
12.3.7. Other
12.4. Market Value Forecast, by Technology, 2017–2031
12.4.1. Mass Spectrometry
12.4.2. Chromatography
12.4.3. Others
12.5. Market Value Forecast, by End-user, 2017–2031
12.5.1. Healthcare Institutes
12.5.2. Biotech & Pharmaceuticals Company
12.5.3. CDMO & CMO
12.5.4. Clinical Research Organizations
12.6. Market Value Forecast, by Country/Sub-region, 2017–2031
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Testing Type
12.7.2. By Application
12.7.3. By Technology
12.7.4. By End-user
12.7.5. By Country/Sub-region
13. Asia Pacific Bioanalytical Testing Services Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Testing Type, 2017–2031
13.2.1. Cell-based Assays
13.2.2. Virology Testing
13.2.3. Serology, Immunogenicity, and Neutralizing Antibodies
13.2.4. Toxicology Services
13.2.5. Biomarker Testing
13.2.6. Pharmacokinetic Testing
13.2.7. Other Services
13.3. Market Value Forecast, by Application, 2017–2031
13.3.1. Oncology
13.3.2. Metabolic Disorders
13.3.3. Neurology
13.3.4. Hematology
13.3.5. Orthopedics
13.3.6. Immunology
13.3.7. Other
13.4. Market Value Forecast, by Technology, 2017–2031
13.4.1. Mass Spectrometry
13.4.2. Chromatography
13.4.3. Others
13.5. Market Value Forecast, by End-user, 2017–2031
13.5.1. Healthcare Institutes
13.5.2. Biotech & Pharmaceuticals Company
13.5.3. CDMO & CMO
13.5.4. Clinical Research Organizations
13.6. Market Value Forecast, by Country/Sub-region, 2017–2031
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Testing Type
13.7.2. By Application
13.7.3. By Technology
13.7.4. By End-user
13.7.5. By Country/Sub-region
14. Latin America Bioanalytical Testing Services Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Testing Type, 2017–2031
14.2.1. Cell-based Assays
14.2.2. Virology Testing
14.2.3. Serology, Immunogenicity, and Neutralizing Antibodies
14.2.4. Toxicology Services
14.2.5. Biomarker Testing
14.2.6. Pharmacokinetic Testing
14.2.7. Other Services
14.3. Market Value Forecast, by Application, 2017–2031
14.3.1. Oncology
14.3.2. Metabolic Disorders
14.3.3. Neurology
14.3.4. Hematology
14.3.5. Orthopedics
14.3.6. Immunology
14.3.7. Other
14.4. Market Value Forecast, by Technology, 2017–2031
14.4.1. Mass Spectrometry
14.4.2. Chromatography
14.4.3. Others
14.5. Market Value Forecast, by End-user, 2017–2031
14.5.1. Healthcare Institutes
14.5.2. Biotech & Pharmaceuticals Company
14.5.3. CDMO & CMO
14.5.4. Clinical Research Organizations
14.6. Market Value Forecast, by Country/Sub-region, 2017–2031
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Testing Type
14.7.2. By Application
14.7.3. By Technology
14.7.4. By End-user
14.7.5. By Country/Sub-region
15. Middle East & Africa Bioanalytical Testing Services Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Testing Type, 2017–2031
15.2.1. Cell-based Assays
15.2.2. Virology Testing
15.2.3. Serology, Immunogenicity, and Neutralizing Antibodies
15.2.4. Toxicology Services
15.2.5. Biomarker Testing
15.2.6. Pharmacokinetic Testing
15.2.7. Other Services
15.3. Market Value Forecast, by Application, 2017–2031
15.3.1. Oncology
15.3.2. Metabolic Disorders
15.3.3. Neurology
15.3.4. Hematology
15.3.5. Orthopedics
15.3.6. Immunology
15.3.7. Other
15.4. Market Value Forecast, by Technology, 2017–2031
15.4.1. Mass Spectrometry
15.4.2. Chromatography
15.4.3. Others
15.5. Market Value Forecast, by End-user, 2017–2031
15.5.1. Healthcare Institutes
15.5.2. Biotech & Pharmaceuticals Company
15.5.3. CDMO & CMO
15.5.4. Clinical Research Organizations
15.6. Market Value Forecast, by Country/Sub-region, 2017–2031
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Testing Type
15.7.2. By Application
15.7.3. By Technology
15.7.4. By End-user
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player - Competition Matrix (by tier and size of companies)
16.2. Company Profiles
16.3. Company Profiles
16.3.1. Charles River Laboratories International, Inc.
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. SWOT Analysis
16.3.1.4. Strategic Overview
16.3.2. Bioreliance Corporation
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. Intertek Group plc
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. SWOT Analysis
16.3.3.4. Strategic Overview
16.3.4. Eurofins Scientific SE
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. BioclinResearch Laboratories
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. Labcorp
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. SWOT Analysis
16.3.6.4. Strategic Overview
16.3.7. Wuxi AppTec
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. Envigo
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. BioAgilytix Labs
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. SWOT Analysis
16.3.9.4. Strategic Overview
16.3.10. SyneosHealth
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Product Portfolio
16.3.10.3. SWOT Analysis
16.3.10.4. Strategic Overview
16.3.11. Frontage Labs
16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.11.2. Product Portfolio
16.3.11.3. SWOT Analysis
16.3.11.4. Strategic Overview

$5,795
$8,795
$11,795

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings